DJ Bristol Myers Squibb Co. Stock Underperforms Monday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Bristol Myers Squibb Co. $(BMY)$ shed 2.60% to $57.58 Monday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average rising 0.38% to 51,850.55 and the S&P 500 Index falling 0.06% to 7,807.24.
This was the stock's third consecutive day of losses.
Bristol Myers Squibb Co. closed 16.11% below its 52-week high of $68.64, which the company achieved on August 19th.
The stock underperformed when compared to some of its competitors Monday, as Johnson & Johnson $(JNJ)$ rose 0.88% to $263.73, Pfizer Inc. $(PFE)$ rose 0.42% to $28.40, and Abbott Laboratories $(ABT)$ rose 2.23% to $101.82.
Trading volume (22.6 M) eclipsed its 50-day average volume of 11.2 M.
Data source: Dow Jones Market Data, FactSet. Data compiled October 12, 2026.